Your browser doesn't support javascript.
loading
Ipilimumab with or without nivolumab in PD-1 or PD-L1 blockade refractory metastatic melanoma: a randomized phase 2 trial.
VanderWalde, Ari; Bellasea, Shay L; Kendra, Kari L; Khushalani, Nikhil I; Campbell, Katie M; Scumpia, Philip O; Kuklinski, Lawrence F; Collichio, Frances; Sosman, Jeffrey A; Ikeguchi, Alexandra; Victor, Adrienne I; Truong, Thach-Giao; Chmielowski, Bartosz; Portnoy, David C; Chen, Yuanbin; Margolin, Kim; Bane, Charles; Dasanu, Constantin A; Johnson, Douglas B; Eroglu, Zeynep; Chandra, Sunandana; Medina, Egmidio; Gonzalez, Cynthia R; Baselga-Carretero, Ignacio; Vega-Crespo, Agustin; Garcilazo, Ivan Perez; Sharon, Elad; Hu-Lieskovan, Siwen; Patel, Sapna P; Grossmann, Kenneth F; Moon, James; Wu, Michael C; Ribas, Antoni.
Afiliação
  • VanderWalde A; The West Clinic-Wolf River, Germantown, TN, USA. avanderwalde@westclinic.com.
  • Bellasea SL; Southwest Oncology Group Statistics and Data Management Center, Seattle, WA, USA.
  • Kendra KL; Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Khushalani NI; Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Campbell KM; Moffitt Cancer Center, Tampa, FL, USA.
  • Scumpia PO; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA.
  • Kuklinski LF; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA.
  • Collichio F; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA.
  • Sosman JA; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.
  • Ikeguchi A; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.
  • Victor AI; University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
  • Truong TG; University of Rochester, Rochester, NY, USA.
  • Chmielowski B; Kaiser Permanente Northern California, Kaiser Permanente National Cancer Institute Community Oncology Research Program, Vallejo, CA, USA.
  • Portnoy DC; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA.
  • Chen Y; The West Clinic-Wolf River, Germantown, TN, USA.
  • Margolin K; Cancer and Hematology Centers of Western Michigan-Cancer Research Consortium of West Michigan, Grand Rapids, MI, USA.
  • Bane C; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Dasanu CA; St. John's Cancer Institute, Santa Monica, CA, USA.
  • Johnson DB; Dayton Physicians LLC, Miami Valley Hospital North, Dayton, OH, USA.
  • Eroglu Z; Lucy Curci Cancer Center, Eisenhower Health, Rancho Mirage, CA, USA.
  • Chandra S; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
  • Medina E; Moffitt Cancer Center, Tampa, FL, USA.
  • Gonzalez CR; Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA.
  • Baselga-Carretero I; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA.
  • Vega-Crespo A; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA.
  • Garcilazo IP; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA.
  • Sharon E; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA.
  • Hu-Lieskovan S; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles, CA, USA.
  • Patel SP; National Cancer Institute, Cancer Therapy Evaluation Program, Bethesda, MD, USA.
  • Grossmann KF; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Moon J; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Wu MC; University of Utah, Huntsman Cancer Institute, Salt Lake City, UT, USA.
  • Ribas A; Merck & Co., Inc., Rahway, NJ, USA.
Nat Med ; 29(9): 2278-2285, 2023 09.
Article em En | MEDLINE | ID: mdl-37592104

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nivolumabe / Melanoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nivolumabe / Melanoma Tipo de estudo: Clinical_trials Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article